Insider Transactions in Q1 2025 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,040
-3.29%
|
$11,040
$1.01 P/Share
|
|
Feb 19
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
10,300
-3.15%
|
$10,300
$1.01 P/Share
|
|
Feb 19
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
23,774
-2.14%
|
$23,774
$1.01 P/Share
|